Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04200534Phase 1Active, not recruiting
Phase 1, randomised, open-label trial (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: Smoking Abstinence Questionnaire at 12 weeks and Lung Cancer Screening 12 items version at 12 weeks. Started Jul 2020; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04200534.